Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
Submitted by
admin
on October 6, 2017 - 11:41am
Source:
Endpoints
News Tags:
Merck
lung cancer
Keytruda
Yervoy
Bristol-Myers Squibb
Headline:
‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
Do Not Allow Advertisers to Use My Personal information
